Compare Albemarle Corp. (ALB) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Albemarle Corp. vs Citius Pharmaceuticals Inc — how do they compare? Albemarle Corp. trades at $131.2 (market cap $15.27B), while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: Albemarle Corp. is far larger — about 763.1× Citius Pharmaceuticals Inc's market cap, and Albemarle Corp. pays a 1.27% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| ALB | CTXR | |
|---|---|---|
Market Cap | $15.27B | $20.01M |
Sector | Basic Materials | Health |
52-Week High | $215.62 | $1.82 |
52-Week Low | $72.58 | $0.48 |
Enterprise Value | $17.75B | $16.23M |
Dividend Yield | 1.27% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Albemarle Corp.
Albemarle is the world's largest lithium producer. Our outlook for robust lithium demand is predicated upon increased demand for electric vehicle batteries. Albemarle produces lithium from its salt brine deposits in Chile and the U.S. and its hard rock joint venture mines in Australia. Albemarle is also a global leader in the production of bromine, used in flame retardants. The company is also a major producer of oil refining catalysts.
Read more on ALB →About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →
